World Ovarian Cancer Day: A Call to Action for Early Detection and Women's Health.

Empowering Early Detection: KHB & Tianlong's Ovarian Cancer Solutions

Ovarian cancer is often called the “silent killer” because its symptoms are vague and easily overlooked. Globally, it is the 8th most common cancer among women, with over 300,000 new cases diagnosed annually and more than 200,000 deaths each year, according to WHO data.

At KHB and Tianlong, we are committed to protecting women's health through advanced diagnostic solutions. Early detection makes all the difference.

Our Ovarian Cancer-Related Diagnostic Offerings:
CA125 & HE4 Tumor Marker Testing – Widely used for ovarian cancer risk assessment, monitoring, and recurrence detection. Combined testing helps improve diagnostic accuracy, especially in postmenopausal women.

Our Broader Oncology Diagnostic Portfolio Includes:
Virus-related cancer detection (HPV, HBV, EBV)
Personalized medicine markers (K-Ras, B-Raf)
Tumor markers for breast, colorectal, and lung cancers
Immunoassay and biochemical tumor marker panels, including CEA, CA19-9, NSE, and more

Prevention & Early Detection Tips:
Know your family history – especially for ovarian or breast cancer
Undergo regular gynecological check-ups, particularly post-menopause
Get screened using CA125 + HE4, or consider genetic testing if high-risk
Maintain a healthy lifestyle – regular exercise, balanced diet, and avoiding smoking

With our comprehensive diagnostic solutions, we empower women and clinicians to detect ovarian and other cancers earlier, faster, and more accurately.